Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Bannon SA"'
Autor:
Stewart BL; Cleveland Clinic, Cleveland, Ohio, USA., Helber H; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; Hematology and Cancer Center, Texas Children's Hospital, Houston, Texas, USA., Bannon SA; National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Deuitch NT; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Ferguson M; GeneDx, Gaithersburg, Maryland, USA., Fiala E; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hamilton KV; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Malcolmson J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Pencheva B; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Smith-Simmer K; Academic Affairs, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; University of Wisconsin Carbone Cancer Center, UW Health, Madison, Wisconsin, USA.
Publikováno v:
Journal of genetic counseling [J Genet Couns] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Autor:
Johnson AQ; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., Bannon SA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Farach LS; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Department of Pediatrics, McGovern Medical School at UT Health, Houston, Texas, USA., Hyde SM; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hashmi SS; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Department of Pediatrics, McGovern Medical School at UT Health, Houston, Texas, USA., Wagner C; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UT Health, Houston, Texas, USA., DiNardo CD; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2023 Jan; Vol. 110 (1), pp. 109-116. Date of Electronic Publication: 2022 Oct 21.
Autor:
DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Estecio M; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hardikar S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khoury JD; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Routbort M; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gong T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kondo K; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Cancer Epigenetics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Epigenetics [Epigenetics] 2021 May; Vol. 16 (5), pp. 567-576. Date of Electronic Publication: 2020 Aug 28.
Autor:
Bannon SA; Department of Clinical Cancer Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Routbort MJ; Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Montalban-Bravo G; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Mehta RS; Department of Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Jelloul FZ; Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Takahashi K; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Daver N; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Oran B; Department of Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Pemmaraju N; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Borthakur G; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Naqvi K; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Issa G; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Sasaki K; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Alvarado Y; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Kadia TM; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Konopleva M; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Shamanna RK; Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Khoury JD; Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Ravandi F; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Champlin R; Department of Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Kantarjian HM; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Bhalla K; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Garcia-Manero G; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., Patel KP; Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States., DiNardo CD; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jan 28; Vol. 10, pp. 582213. Date of Electronic Publication: 2021 Jan 28 (Print Publication: 2020).
Autor:
Abou Dalle I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Routbort M; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bhalla K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
American journal of hematology [Am J Hematol] 2020 Feb; Vol. 95 (2), pp. 227-229. Date of Electronic Publication: 2019 Aug 29.
Autor:
Alfayez M; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Wang SA; b Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Bannon SA; c Clinical Cancer Genetics Program , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Kontoyiannis DP; d Department of Infectious Diseases , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Kornblau SM; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Orange JS; e Department of Pediatrics , Columbia University Medical Center , New York , NY , USA., Mace EM; e Department of Pediatrics , Columbia University Medical Center , New York , NY , USA., DiNardo CD; a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Aug; Vol. 60 (8), pp. 2025-2033. Date of Electronic Publication: 2019 Jan 16.
Autor:
Quesada AE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Routbort MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zuo Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Benton CB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
American journal of hematology [Am J Hematol] 2019 Jul; Vol. 94 (7), pp. 757-766. Date of Electronic Publication: 2019 May 07.
Autor:
Mork ME; Clinical Cancer Genetics Program, UT MD Anderson Cancer Center, Unit 1354, 1155 Pressler St., Houston, TX 77030, USA., Rodriguez A; Department of Clinical Cancer Prevention, UT MD Anderson Cancer Center, Unit 1360, P.O. Box 301439, Houston, TX 77230-1439, USA., Bannon SA; Clinical Cancer Genetics Program, UT MD Anderson Cancer Center, Unit 1354, 1155 Pressler St., Houston, TX 77030, USA., Lynch PM; Department of Gastroenterology, Hepatology, and Nutrition, UT MD Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd., Houston, TX 77030, USA., Rodriguez-Bigas MA; Department of Surgical Oncology, UT MD Anderson Cancer Center, Unit 1484, 1400 Pressler St., Houston, TX 77030, USA., Thirumurthi S; Department of Gastroenterology, Hepatology, and Nutrition, UT MD Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd., Houston, TX 77030, USA., You YN; Department of Surgical Oncology, UT MD Anderson Cancer Center, Unit 1484, 1400 Pressler St., Houston, TX 77030, USA., Vilar E; Department of Clinical Cancer Prevention, UT MD Anderson Cancer Center, Unit 1360, P.O. Box 301439, Houston, TX 77230-1439, USA; Gastrointestinal Medical Oncology, UT MD Anderson Cancer Center, Unit 426, 1515 Holcombe Blvd., Houston, TX 77030, USA. Electronic address: evilar@mdanderson.org.
Publikováno v:
Cancer genetics [Cancer Genet] 2019 Jun; Vol. 235-236, pp. 77-83. Date of Electronic Publication: 2019 Apr 26.
Autor:
Abou Dalle I; The University of Texas MD Anderson Cancer Center, Houston, TX., Bannon SA; The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KP; The University of Texas MD Anderson Cancer Center, Houston, TX., Routbort MJ; The University of Texas MD Anderson Cancer Center, Houston, TX., Cortes JE; The University of Texas MD Anderson Cancer Center, Houston, TX., Ferrajoli A; The University of Texas MD Anderson Cancer Center, Houston, TX., Kontoyiannis DP; The University of Texas MD Anderson Cancer Center, Houston, TX., Wang SA; The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2019 Mar 04; Vol. 3. Date of Electronic Publication: 2019 Mar 04 (Print Publication: 2019).
Autor:
Swaminathan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Bannon SA; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Routbort M; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., Strong L; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
Publikováno v:
Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2019 Feb 01; Vol. 5 (1). Date of Electronic Publication: 2019 Feb 01 (Print Publication: 2019).